Long-term effects of moderate vs high durations of aerobic exercise on biomarkers of breast cancer risk: Follow-up to a randomized controlled trial
Cancer Epidemiology, Biomarkers & Prevention Sep 19, 2019
Friedenreich CM, Wang Q, Yasui Y, et al. - Researchers investigated the influence of the amount of exercise prescribed in a year-long exercise intervention on breast cancer biomarker levels (C-reactive protein, insulin, glucose, HOMA-IR, estrone, sex hormone binding globulin, total estradiol, and free estradiol) 1 year later. A 24-month follow-up study (2012–2014) to the Breast Cancer and Exercise Trial in Alberta (BETA; a 12-month, two-armed (1:1), two-center randomized controlled trial of exercise in 400 cancer-free, postmenopausal women) was performed. Patients were asked to perform moderate–vigorous aerobic exercise, 5 days/week (3 days/week supervised) for 30 minutes/session (MODERATE) or 60 minutes/session (HIGH). Outcomes revealed no effects on longer-term biomarkers when the aerobic exercise was prescribed for 300 vs 150 minutes/week for 12 months to inactive, postmenopausal women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries